查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1929627

醫療設備射出成型機市場：依機器類型、材料類型、扣夾力和應用分類，全球預測（2026-2032年）

Medical Device Injection Molding Machine Market by Machine Type, Material Type, Clamping Force, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，醫療設備射出成型機市場價值將達到 6.5484 億美元，到 2026 年將成長至 7.0614 億美元，到 2032 年將達到 10.2037 億美元，複合年成長率為 6.54%。

關鍵市場統計數據
基準年 2025 6.5484億美元
預計年份：2026年 7.0614億美元
預測年份 2032 1,020,370,000 美元
複合年成長率 (%) 6.54%

針對醫療設備射出成型機市場趨勢的全面指導，重點在於技術選擇、監管挑戰和採購重點。

醫療設備射出成型產業處於精密製造、嚴格法律規範以及對用於植入、器械和一次性產品的聚合物基組件日益成長的需求三者交匯的階段。材料科學的進步、日益嚴格的臨床規範以及對自動化需求的不斷成長，正推動著對設備性能、重複性和可追溯性的要求不斷提高。隨著製造商力求提高營運效率和產量比率，機器可靠性、製程控制以及與數位化品質系統的整合已成為關鍵的採購標準。

自動化、材料創新和監管要求如何共同作用，重新定義注塑設備的採購標準和營運預期

受技術、監管和營運因素的影響，醫療設備射出成型機的市場環境正在經歷變革性變化。自動化和工業4.0整合已不再是可選項，而是確保合規性和可追溯性的基礎生產技術。封閉回路型過程控制、在線連續檢測以及機器與製造執行系統（MES）的連接在降低變異性和應對監管審查方面發揮核心作用。同時，伺服驅動系統和混合配置的進步正在重新定義週期時間和能源效率的預期，並改變企業生命週期內總擁有成本（TCO）的計算方式。

貿易政策的變化迫使企業重新調整籌資策略和供應商選擇，同時最佳化生命週期成本以降低關稅風險。

2025年的關稅趨勢和不斷變化的貿易政策給射出成型設備行業的製造商和資本支出負責人帶來了新的挑戰。關稅表的變化對精密機械和關鍵子系統的進口成本產生了相對影響，進而影響了籌資策略、供應商選擇和總到岸成本的計算。採購團隊不得不重新審視其供應商組合，並重新評估國內採購、近岸外包和傳統進口管道之間的權衡取捨。

將機器架構、材料相容性、夾緊力範圍和應用需求與採購和檢驗策略連結起來的詳細細分分析

細分分析揭示了機器架構、材料相容性、夾緊力要求和最終用途等明確的決策促進因素，這些因素分別指導採購和製程設計。根據機器類型，市場可分為全電動、混合動力和液壓三種類型。每種架構各有優勢：全電動系統通常因其精度、重複性和能源效率而備受青睞，而混合動力平台則在中高負載環境下實現了力和速度的平衡。液壓機械在高噸位、高壓應用中保持主導地位，在這些應用中，純粹的力是關鍵參數。

區域管理體制、供應鏈生態系統和服務網路如何推動全球差異化的設施策略和製造地選址

區域趨勢持續以顯著不同的方式影響美洲、歐洲、中東和非洲以及亞太地區的製造地、供應商生態系統和服務網路。在美洲，製造商通常優先考慮與本地供應商建立關係、提供快速回應的售後支援以及遵守關鍵監管機構的規定，從而推動對模組化生產線和本地服務能力的投資。同時，在歐洲、中東和非洲，對嚴格監管協調、永續性要求和能源效率目標的共同關注，推動了先進控制系統和閉合迴路品質監控技術的應用。

供應商格局分析：重點闡述OEM創新、專業知識和不斷發展的服務將如何重塑採購標準和夥伴關係模式

射出成型設備產業的企業層面趨勢顯示，全球原始設備製造商 (OEM)、專業細分領域供應商和垂直整合供應商共同構成了一個多元化的市場，為醫療設備製造商提供專業解決方案。主要企業正大力投資數位化，提供涵蓋製程控制、統計製程控制 (SPC) 分析和製造執行系統 (MES)互通性的整合軟體套件，以支援端到端的可追溯性和快速驗證週期。同時，專業供應商則專注於特定領域，例如用於植入的微成型、彈性體複合技術或針對厚壁零件最佳化的高噸位壓平機，為具有特定技術需求的製造商提供寶貴的選擇。

在採購、營運和供應商管治採取切實可行的優先行動，以縮短檢驗時間、提高韌性並最佳化全生命週期成果。

為保持競爭力並確保合規性，產業領導者應在採購、營運和供應商協作方面採取重點突出的執行策略。首先，將數位化應對力作為採購文件中的關鍵規範，確保機器支援安全的資料收集、與企業系統的整合以及用於流程最佳化的高階分析。其次，優先採用模組化機器設計，允許逐步擴展產能和升級零件，而無需更換整個系統，從而降低資本投入並縮短檢驗週期。

我們採用透明且可複製的調查方法，結合一手訪談、技術檢驗和工程績效指標，以確保實際相關性。

本研究整合了訪談資料、行業文獻、技術白皮書和檢驗的工程資訊，旨在深入了解設備性能、採購促進因素和運營限制。訪談資料包括對製造工程師、品質主管、採購經理和售後服務專業人員的結構化訪談，以了解實際決策標準、挑戰和所需的機器功能。二級資訊來源包括製造商技術規格、監管指導文件和同行評審的工程研究，以檢驗性能特徵和技術發展趨勢。

整合策略需求：機器選擇、檢驗嚴謹性和供應商策略如何共同決定製造的韌性和競爭力

總之，目前醫療設備射出成型設備的現況需要一種兼顧技術能力、法規遵循和供應鏈韌性的策略方法。機器架構、材料相容性、夾緊力力以及應用需求構成了驅動採購和營運規劃的核心決策矩陣。數位控制、自動化和材料科學的進步正在重新定義採購方應優先考慮的屬性，而貿易政策和區域趨勢則帶來了影響採購和生命週期成本的實際考慮。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章醫療設備射出成型機市場（按類型分類）

  • 全電動
  • 混合
  • 油壓

第9章醫療設備射出成型機市場（依材料類型分類）

  • 彈性體
  • 熱塑性樹脂
  • 熱固性樹脂

第10章夾緊力分類的醫療設備射出成型機市場

  • 500至1000噸
  • 超過1000噸
  • 不到500噸

第11章醫療設備射出成型機市場（依應用領域分類）

  • 植入
  • 手術器械
  • 注射器

第12章醫療設備射出成型機市場（按地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章醫療設備射出成型機市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國醫療設備射出成型機市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國醫療設備射出成型機市場

第16章 中國醫療設備射出成型機市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • ARBURG GmbH+Co KG
  • Battenfeld-Cincinnati Austria GmbH
  • BOY Machines, Inc.
  • Chen Hsong Holdings Limited
  • ENGEL Austria GmbH
  • FANUC Corporation
  • Haitian International Holdings Limited
  • Husky Injection Molding Systems Ltd.
  • JSW Plastics Machinery Inc.
  • KraussMaffei Group GmbH
  • LS Mtron Ltd.
  • Milacron Holdings Corp.
  • Negri Bossi SpA
  • Niigata Machine Techno Co., Ltd.
  • Nissei Plastic Industrial Co., Ltd.
  • Plastiblow Srl
  • Powerjet Plastic Machinery Co., Ltd.
  • Shibaura Machine Co., Ltd.
  • Sodick Co., Ltd.
  • Sumitomo Heavy Industries, Ltd.
  • Tederic Machinery Co., Ltd.
  • Toshiba Machine Co., Ltd.
  • Ube Machinery Corporation, Ltd.
  • Wittmann Battenfeld GmbH
  • Yizumi Precision Machinery Co., Ltd.
Product Code: MRR-0A3806951856

The Medical Device Injection Molding Machine Market was valued at USD 654.84 million in 2025 and is projected to grow to USD 706.14 million in 2026, with a CAGR of 6.54%, reaching USD 1,020.37 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 654.84 million
Estimated Year [2026] USD 706.14 million
Forecast Year [2032] USD 1,020.37 million
CAGR (%) 6.54%

Comprehensive orientation to the medical device injection molding machine landscape, highlighting technology choices, regulatory intersections, and procurement priorities

The medical device injection molding machine sector sits at the intersection of precision manufacturing, stringent regulatory oversight, and accelerating demand for polymer-based components used across implants, instruments, and disposables. Advances in materials science, tighter clinical specifications, and increasing automation imperatives have raised the bar for equipment performance, repeatability, and traceability. As manufacturers pursue leaner operations and higher yields, machine reliability, process control, and integration with digital quality systems have become primary purchasing criteria.

This report provides an evidence-based orientation for leaders who must reconcile capital intensity with the need for agility in producing mission-critical components. It frames the core technology choices that shape production outcomes-machine architecture, material compatibility, and clamping force ranges-while situating these within regulatory and supply chain realities. Readers will find a narrative that links engineering options to operational outcomes, so capital planners, quality leads, and R&D teams can prioritize investments that reduce scrap, shorten validation cycles, and enhance throughput.

Understanding this context is crucial for decision-makers seeking to align equipment acquisition with broader clinical and commercial goals, including speed to market, consistent product quality, and cost-effective manufacturing at scale.

How automation, materials innovation, and regulatory demands are jointly redefining procurement criteria and operational expectations for molding equipment

The landscape for medical device injection molding machines is undergoing transformative shifts driven by technological, regulatory, and operational forces. Automation and Industry 4.0 integrations have moved beyond optional upgrades to become enablers of compliant, traceable production; closed-loop process controls, inline inspection, and machine-to-MES connectivity are now central to reducing variability and satisfying regulatory scrutiny. Concurrently, advances in servo-driven systems and hybrid configurations have redefined expectations for cycle times and energy efficiency, altering total cost of ownership calculations across procurement horizons.

Material innovation has also reshaped machine requirements. Emerging thermoplastic and elastomer formulations demand precise thermal and shear control, pressing manufacturers to adopt machines with finer injection profiling and faster tool-change capabilities. Regulatory expectations for serialization, lot traceability, and implantable device validation have further prioritized machines that support extensive data capture and secure retention of process records.

Supply chain resilience concerns have prompted regionalization strategies, encouraging manufacturers to prioritize equipment that supports modular lines and rapid qualification. As a result, procurement decisions increasingly weigh operational flexibility, digital readiness, and validation support just as heavily as traditional metrics such as throughput and energy consumption. This confluence of trends is driving a new generation of procurement criteria that tie capital investment directly to compliance, speed, and adaptability.

Trade policy changes are reshaping sourcing strategies and supplier selection while forcing lifecycle cost optimization to mitigate tariff exposure risks

Tariff dynamics and trade policy shifts in 2025 introduced a new layer of complexity for manufacturers and capital planners in the injection molding equipment space. Changes to tariff schedules have affected the relative cost of importing precision machinery and critical subsystems, which has in turn influenced sourcing strategies, supplier selection, and total landed cost calculations. Procurement teams have had to revisit their supplier portfolios and reassess the trade-offs between domestic sourcing, nearshoring, and traditional import channels.

These tariff-related pressures have accelerated conversations around supplier diversification and vendor partnerships that can provide onshore assembly, local service networks, and expedited spare parts provisioning. Capital planning cycles now incorporate scenario analyses that account for tariff variability and potential supply interruptions. Engineering teams are prioritizing equipment that minimizes dependency on single-origin subsystems and that offers modularity to facilitate upgrades without full-system replacement.

Moreover, tariff-induced cost pressures have increased the emphasis on lifecycle cost optimization: energy efficiency, predictive maintenance capabilities, and tooling standardization are being evaluated not just for operational benefits but as mitigants to trade-policy exposure. In short, the tariff environment has prompted a strategic reorientation toward more resilient sourcing models and equipment choices that reduce exposure to cross-border cost volatility.

In-depth segmentation mapping that links machine architecture, material compatibility, clamping force ranges, and application demands to procurement and validation strategies

Segmentation analysis reveals distinct decision levers across machine architecture, material compatibility, clamping force requirements, and end-use applications, each of which informs procurement and process design pathways. Based on Machine Type, market is studied across All Electric, Hybrid, and Hydraulic. Each architecture brings differentiated strengths: all-electric systems are often favored for precision, repeatability, and energy efficiency; hybrid platforms balance force and speed for medium-to-high demand contexts; hydraulic machines retain advantages for high-tonnage, high-pressure applications where raw force is a critical parameter.

Based on Material Type, market is studied across Elastomer, Thermoplastic, and Thermoset. Material selection drives machine thermal management, screw/channel design, and mold-release strategies; elastomers require specialized handling to control cure and post-process distortion, while thermoplastics demand tight melt-temperature control and rapid cycle profiling. Thermosets introduce unique curing and demolding considerations that influence cycle planning and tooling investment.

Based on Clamping Force, market is studied across 500 To 1000 Tons, Above 1000 Tons, and Less Than 500 Tons. Clamping force categories map directly to component geometry, cavity count, and wall thickness requirements; lower-tonnage machines afford high-cavity, thin-walled consumer-type components, whereas higher-tonnage equipment supports larger implants, multi-drop tools, and deep-draw geometries. Based on Application, market is studied across Implants, Surgical Instruments, and Syringes. Application-driven constraints determine cleanliness regimes, material traceability needs, and validation intensity; implants require the most stringent validation and surface-finish control, surgical instruments prioritize dimensional stability and sterilization compatibility, and syringes emphasize cycle consistency and contamination control.

Taken together, these segmentation dimensions create a matrix that informs machine selection, line architecture, and validation planning. Procurement leaders should align machine capabilities with the dominant material and clamping force demands of targeted applications to ensure process capability and regulatory compliance.

How regional regulatory regimes, supply ecosystems, and service networks are driving differentiated equipment strategies and manufacturing footprints globally

Regional dynamics continue to shape manufacturing footprints, supplier ecosystems, and service networks in materially different ways across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, manufacturers often prioritize localized supplier relationships, rapid aftermarket support, and compliance pathways aligned with dominant regulatory authorities; these factors encourage investments in modular lines and onshore service capabilities. Conversely, Europe, Middle East & Africa typically emphasize stringent regulatory harmonization, sustainability mandates, and energy efficiency targets, driving uptake of advanced control systems and closed-loop quality monitoring.

Asia-Pacific remains a critical hub for component manufacturing and increasingly for higher-value equipment assembly. Its dense supplier networks and expanding capital equipment vendors provide competitive options for cost-sensitive production, though buyers must weigh variances in service coverage and qualification support. Regional labor costs, freight dynamics, and regulatory nuances combine to influence total cost of ownership, making geography a central concern for capital planning.

Given these differences, manufacturers adopt a hybrid approach that balances local responsiveness with the technical strengths of global suppliers. Equipment choices and aftermarket strategies are therefore tailored to the region's regulatory, logistical, and labor environment to optimize uptime, validation velocity, and operational resilience across distributed production sites.

Vendor landscape analysis highlighting how OEM innovation, specialist capabilities, and service evolution are reshaping procurement criteria and partnership models

Company-level dynamics in the injection molding equipment space reveal a landscape characterized by a mix of global OEMs, niche specialists, and vertically integrated suppliers that offer tailored solutions for medical device manufacturers. Leading equipment producers are investing heavily in digitalization, offering integrated software suites that span process control, SPC analytics, and MES interoperability to support end-to-end traceability and faster validation cycles. Meanwhile, specialist vendors focus on niche capabilities-such as implant-focused micro-molding, elastomer compounding expertise, or high-tonnage presses optimized for thick-walled components-providing valuable options for manufacturers with specific technical requirements.

Service models have evolved from reactive maintenance to subscription-like offerings that include predictive analytics, remote diagnostics, and prioritized spare parts provisioning. This shift reduces downtime risk and shortens qualification windows by enabling remote troubleshooting during validation runs. Partnerships between equipment suppliers and tooling houses have become more common, streamlining co-development of molds and machine configurations that minimize cycle time and scrap.

For procurement teams, vendor selection increasingly hinges on the availability of robust validation support, local service coverage, and a clear roadmap for software upgrades and cybersecurity provisioning. Companies that can combine machine performance with a suite of services that accelerates time-to-qualification will command a competitive advantage among medical device manufacturers.

Practical, prioritized actions for procurement, operations, and supplier governance that reduce validation time, improve resilience, and optimize total lifecycle outcomes

To maintain competitiveness and ensure compliance, industry leaders should adopt a set of focused, actionable priorities that span procurement, operations, and supplier collaboration. First, incorporate digital readiness as a primary specification in procurement documents so that machines support secure data capture, integration with enterprise systems, and advanced analytics for process optimization. Second, prioritize modular machine designs that allow incremental capacity expansion and component upgrades without full-system replacement, thereby reducing capital intensity and shortening validation cycles.

Third, strengthen supplier governance by mandating service-level agreements that include rapid spare parts delivery, on-site validation assistance, and remote diagnostic access. This approach mitigates downtime risk and accelerates qualification. Fourth, align material selection strategies with machine capabilities early in product development to minimize post-qualification adjustments and to ensure consistent clinical performance. Fifth, develop a cross-functional validation playbook that defines standard protocols for installation, operational, and performance qualification, enabling repeatable and auditable qualification across sites.

Finally, invest in workforce competencies around process monitoring, statistical process control, and digital maintenance tools to extract full value from advanced equipment. These actions collectively reduce operational friction, improve process capability, and position manufacturers to respond rapidly to regulatory shifts and market demand changes.

Transparent, reproducible research methodology combining primary interviews, technical verification, and engineering performance metrics to ensure practical relevance

This study synthesizes primary interviews, secondary industry literature, technical white papers, and validated engineering inputs to construct a robust understanding of equipment performance, procurement drivers, and operational constraints. Primary research included structured interviews with manufacturing engineers, quality leads, procurement managers, and aftermarket service professionals to capture real-world decision criteria, pain points, and desired machine features. Secondary sources comprised manufacturer technical specifications, regulatory guidance documents, and peer-reviewed engineering research to verify performance characteristics and technology trends.

Data triangulation was applied to reconcile divergent inputs and to ensure the analytical narrative reflects both practitioner experience and documented engineering performance. The methodology prioritized reproducibility by documenting interview protocols, key assumptions, and criteria for technology categorization. Comparative analysis across machine architectures, materials, clamping force categories, and applications was conducted using engineering performance indicators such as cycle stability, thermal control precision, and cleanroom compatibility.

Limitations were acknowledged where proprietary performance metrics or recent tariff adjustments introduced uncertainty; where possible, sensitivity analyses were used to illustrate how equipment selection trade-offs change under different operational constraints. The resulting methodology emphasizes transparency, practitioner relevance, and technical rigor to support confident decision-making by equipment buyers and operations leaders.

Synthesis of strategic imperatives showing how machine choices, validation rigor, and supplier strategies converge to determine manufacturing resilience and competitiveness

In conclusion, the medical device injection molding equipment landscape demands a strategic approach that balances technological capability, regulatory compliance, and supply chain resilience. Machine architecture, material compatibility, clamping force capacity, and application requirements form the core decision matrix that drives procurement and operational planning. Advances in digital controls, automation, and materials science are reshaping the attributes buyers must prioritize, while trade policy and regional dynamics introduce practical considerations that affect sourcing and lifecycle costs.

Manufacturers that align equipment selection with rigorous validation playbooks, strong supplier partnerships, and modular system designs will be best positioned to reduce time-to-market and maintain consistent clinical-grade output. Investments in digital readiness and predictive service models deliver tangible operational benefits, including reduced downtime and faster qualification. Ultimately, the ability to translate machine capabilities into validated, repeatable processes is the defining factor that determines manufacturing resilience and competitive advantage.

Leaders should therefore approach equipment decisions not as discrete purchases but as strategic enablers that require coordinated planning across engineering, quality, and procurement to realize sustained operational improvements.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Medical Device Injection Molding Machine Market, by Machine Type

  • 8.1. All Electric
  • 8.2. Hybrid
  • 8.3. Hydraulic

9. Medical Device Injection Molding Machine Market, by Material Type

  • 9.1. Elastomer
  • 9.2. Thermoplastic
  • 9.3. Thermoset

10. Medical Device Injection Molding Machine Market, by Clamping Force

  • 10.1. 500 To 1000 Tons
  • 10.2. Above 1000 Tons
  • 10.3. Less Than 500 Tons

11. Medical Device Injection Molding Machine Market, by Application

  • 11.1. Implants
  • 11.2. Surgical Instruments
  • 11.3. Syringes

12. Medical Device Injection Molding Machine Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Medical Device Injection Molding Machine Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Medical Device Injection Molding Machine Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Medical Device Injection Molding Machine Market

16. China Medical Device Injection Molding Machine Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. ARBURG GmbH + Co KG
  • 17.6. Battenfeld-Cincinnati Austria GmbH
  • 17.7. BOY Machines, Inc.
  • 17.8. Chen Hsong Holdings Limited
  • 17.9. ENGEL Austria GmbH
  • 17.10. FANUC Corporation
  • 17.11. Haitian International Holdings Limited
  • 17.12. Husky Injection Molding Systems Ltd.
  • 17.13. JSW Plastics Machinery Inc.
  • 17.14. KraussMaffei Group GmbH
  • 17.15. LS Mtron Ltd.
  • 17.16. Milacron Holdings Corp.
  • 17.17. Negri Bossi S.p.A.
  • 17.18. Niigata Machine Techno Co., Ltd.
  • 17.19. Nissei Plastic Industrial Co., Ltd.
  • 17.20. Plastiblow Srl
  • 17.21. Powerjet Plastic Machinery Co., Ltd.
  • 17.22. Shibaura Machine Co., Ltd.
  • 17.23. Sodick Co., Ltd.
  • 17.24. Sumitomo Heavy Industries, Ltd.
  • 17.25. Tederic Machinery Co., Ltd.
  • 17.26. Toshiba Machine Co., Ltd.
  • 17.27. Ube Machinery Corporation, Ltd.
  • 17.28. Wittmann Battenfeld GmbH
  • 17.29. Yizumi Precision Machinery Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY MACHINE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY CLAMPING FORCE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY MACHINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY ALL ELECTRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY ALL ELECTRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY ALL ELECTRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY HYBRID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY HYBRID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY HYBRID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY HYDRAULIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY HYDRAULIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY HYDRAULIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY ELASTOMER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY ELASTOMER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY ELASTOMER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY THERMOPLASTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY THERMOPLASTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY THERMOPLASTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY THERMOSET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY THERMOSET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY THERMOSET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY CLAMPING FORCE, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY 500 TO 1000 TONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY 500 TO 1000 TONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY 500 TO 1000 TONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY ABOVE 1000 TONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY ABOVE 1000 TONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY ABOVE 1000 TONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY LESS THAN 500 TONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY LESS THAN 500 TONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY LESS THAN 500 TONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY SURGICAL INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY SURGICAL INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY SURGICAL INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY SYRINGES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY SYRINGES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY SYRINGES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. AMERICAS MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 44. AMERICAS MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY MACHINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 45. AMERICAS MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 46. AMERICAS MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY CLAMPING FORCE, 2018-2032 (USD MILLION)
  • TABLE 47. AMERICAS MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 48. NORTH AMERICA MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. NORTH AMERICA MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY MACHINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 50. NORTH AMERICA MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 51. NORTH AMERICA MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY CLAMPING FORCE, 2018-2032 (USD MILLION)
  • TABLE 52. NORTH AMERICA MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 53. LATIN AMERICA MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. LATIN AMERICA MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY MACHINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 55. LATIN AMERICA MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 56. LATIN AMERICA MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY CLAMPING FORCE, 2018-2032 (USD MILLION)
  • TABLE 57. LATIN AMERICA MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY MACHINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY CLAMPING FORCE, 2018-2032 (USD MILLION)
  • TABLE 62. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 63. EUROPE MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. EUROPE MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY MACHINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 65. EUROPE MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 66. EUROPE MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY CLAMPING FORCE, 2018-2032 (USD MILLION)
  • TABLE 67. EUROPE MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 68. MIDDLE EAST MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. MIDDLE EAST MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY MACHINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 70. MIDDLE EAST MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 71. MIDDLE EAST MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY CLAMPING FORCE, 2018-2032 (USD MILLION)
  • TABLE 72. MIDDLE EAST MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 73. AFRICA MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. AFRICA MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY MACHINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 75. AFRICA MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 76. AFRICA MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY CLAMPING FORCE, 2018-2032 (USD MILLION)
  • TABLE 77. AFRICA MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY MACHINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY CLAMPING FORCE, 2018-2032 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. ASEAN MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. ASEAN MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY MACHINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 86. ASEAN MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 87. ASEAN MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY CLAMPING FORCE, 2018-2032 (USD MILLION)
  • TABLE 88. ASEAN MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 89. GCC MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GCC MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY MACHINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. GCC MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. GCC MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY CLAMPING FORCE, 2018-2032 (USD MILLION)
  • TABLE 93. GCC MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPEAN UNION MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPEAN UNION MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY MACHINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPEAN UNION MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPEAN UNION MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY CLAMPING FORCE, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPEAN UNION MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 99. BRICS MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. BRICS MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY MACHINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. BRICS MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. BRICS MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY CLAMPING FORCE, 2018-2032 (USD MILLION)
  • TABLE 103. BRICS MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 104. G7 MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. G7 MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY MACHINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. G7 MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. G7 MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY CLAMPING FORCE, 2018-2032 (USD MILLION)
  • TABLE 108. G7 MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. NATO MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. NATO MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY MACHINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. NATO MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. NATO MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY CLAMPING FORCE, 2018-2032 (USD MILLION)
  • TABLE 113. NATO MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. UNITED STATES MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 116. UNITED STATES MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY MACHINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. UNITED STATES MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. UNITED STATES MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY CLAMPING FORCE, 2018-2032 (USD MILLION)
  • TABLE 119. UNITED STATES MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 120. CHINA MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 121. CHINA MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY MACHINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. CHINA MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. CHINA MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY CLAMPING FORCE, 2018-2032 (USD MILLION)
  • TABLE 124. CHINA MEDICAL DEVICE INJECTION MOLDING MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)